Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Vaccine Group, a UK-based animal disease vaccine spinout of University of Plymouth, has obtained £680,000 ($883,000) in its first funding round, valuing the business at $12.3m. Commercialisation firm Frontier IP owns a 17% stake in Vaccine Group, however investors in the round were not disclosed. Vaccine Group is targeting animal and livestock-borne diseases using vaccines to insert non-infectious pathogen DNA into a benign virus vector – the herpes virus – common across all animal species. The company has received government…
